Suchbegriffe: VALSARTAN, . Treffer: 9
Primessnig, U; Deißler, PM; Wakula, P; Tran, KL; Hohendanner, F; von, Lewinski, D; Blaschke, F; Knosalla, C; Falk, V; Pieske, B; Grubitzsch, H; Heinzel, FR
Effects of BNP and Sacubitrilat/Valsartan on Atrial Functional Reserve and Arrhythmogenesis in Human Myocardium.
FRONT CARDIOVASC MED. 2022; 9: 859014
Doi: 10.3389/fcvm.2022.859014
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abdellatif, M; Lam, CSP
Scientists on the Spot: A fraction of wisdom on heart failure
CARDIOVASC RES. 2021; 117(9): E114-E115.
Doi: 10.1093/cvr/cvab230
Web of Science
PubMed
FullText
FullText_MUG
Solomon, SD; Rizkala, AR; Lefkowitz, MP; Shi, VC; Gong, J; Anavekar, N; Anker, SD; Arango, JL; Arenas, JL; Atar, D; Ben-Gal, T; Boytsov, SA; Chen, CH; Chopra, VK; Cleland, J; Comin-Colet, J; Duengen, HD; Echeverría Correa, LE; Filippatos, G; Flammer, AJ; Galinier, M; Godoy, A; Goncalvesova, E; Janssens, S; Katova, T; Køber, L; Lelonek, M; Linssen, G; Lund, LH; O'Meara, E; Merkely, B; Milicic, D; Oh, BH; Perrone, SV; Ranjith, N; Saito, Y; Saraiva, JF; Shah, S; Seferovic, PM; Senni, M; Sibulo, AS; Sim, D; Sweitzer, NK; Taurio, J; Vinereanu, D; Vrtovec, B; Widimský, J; Yilmaz, MB; Zhou, J; Zweiker, R; Anand, IS; Ge, J; Lam, CSP; Maggioni, AP; Martinez, F; Packer, M; Pfeffer, MA; Pieske, B; Redfield, MM; Rouleau, JL; Van Veldhuisen, DJ; Zannad, F; Zile, MR; McMurray, JJV
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Circ Heart Fail. 2018; 11(7):e004962-e004962
Doi: 10.1161/CIRCHEARTFAILURE.118.004962
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zile, MR; Jhund, PS; Baicu, CF; Claggett, BL; Pieske, B; Voors, AA; Prescott, MF; Shi, V; Lefkowitz, M; McMurray, JJ; Solomon, SD; Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction (PARAMOUNT) Investigators
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
Circ Heart Fail. 2016; 9(1):
Doi: 10.1161/CIRCHEARTFAILURE.115.002551
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jhund, PS; Claggett, B; Packer, M; Zile, MR; Voors, AA; Pieske, B; Lefkowitz, M; Shi, V; Bransford, T; McMurray, JJ; Solomon, SD
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
Eur J Heart Fail. 2014; 16(6):671-677
Doi: 10.1002/ejhf.76
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jhund, PS; Claggett, BL; Voors, AA; Zile, MR; Packer, M; Pieske, BM; Kraigher-Krainer, E; Shah, AM; Prescott, MF; Shi, V; Lefkowitz, M; McMurray, JJ; Solomon, SD; PARAMOUNT Investigators
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
Circ Heart Fail. 2014; 7(6):953-959
Doi: 10.1161/CIRCHEARTFAILURE.114.001427
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kraigher-Krainer, E; Shah, AM; Gupta, DK; Santos, A; Claggett, B; Pieske, B; Zile, MR; Voors, AA; Lefkowitz, MP; Packer, M; McMurray, JJ; Solomon, SD; PARAMOUNT Investigators
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2014; 63(5):447-456
Doi: 10.1016/j.jacc.2013.09.052
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Parthasarathy, HK; Pieske, B; Weisskopf, M; Andrews, CD; Brunel, P; Struthers, AD; MacDonald, TM
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction
Eur J Heart Fail. 2009; 11(10):980-989
Doi: 10.1093/eurjhf/hfp120
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Sen, U; Herrmann, M; Herrmann, W; Tyagi, SC
Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling.
Clin Chem Lab Med. 2007; 45(12):1771-1776
Doi: 10.1515/CCLM.2007.354
Web of Science
PubMed
FullText
FullText_MUG